Article info
PDFShort report
Oral anticancer medicines in acute oncology; recognition by non-specialist clinicians and risk reduction measures
- Correspondence to Carl D Booth, Lead Pharmacist for Cancer Services, Pharmacy Department, Airedale NHS Foundation Trust, Airedale General Hospital, Skipton Road, Steeton, Keighley, West Yorkshire, BD20 6TD, UK; carl.booth{at}anhst.nhs.uk
Citation
Oral anticancer medicines in acute oncology; recognition by non-specialist clinicians and risk reduction measures
Publication history
- Received January 18, 2016
- Revised March 22, 2016
- Accepted April 7, 2016
- First published April 27, 2016.
Online issue publication
May 01, 2020
Article Versions
- Previous version (28 June 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/